CLINICAL_TRIALS
trial_result
· 2013-01-08
Clinical Trial Update: Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia [Phase 1]
Summary
Phase 1 clinical trial evaluating dasatinib in patients with chronic myeloid leukemia or acute lymphoblastic leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Leukemia | Phase 1 | Status: COMPLETED